EU to purchase up to 300 mln doses of BioNTech Pfizer vaccine
Topics: BIONTECH PFIZER
The contract, due to be reached, will be the fourth one the EU secures with a pharmaceutical company to buy vaccines for coronavirus.
The BioNTech Pfizer vaccine candidate has proved to be more than 90 percent effective in preventing coronavirus infection in participants with no proven previous SARS-CoV-2 infection, the two companies announced on Monday. ■